Constitutive activation of Gαq signaling by mutations in GNAQ or GNA11 occurs in over 80% of uveal melanomas (UMs) and activates MAPK. Protein kinase C (PKC) has been implicated as a link, but the mechanistic details remained unclear. We identified PKC δ and ɛ as required and sufficient to activate MAPK in GNAQ mutant melanomas. MAPK activation depends on Ras and is caused by RasGRP3, which is significantly and selectively overexpressed in response to GNAQ/11 mutation in UM. RasGRP3 activation occurs via PKC δ- and ɛ-dependent phosphorylation and PKC-independent, DAG-mediated membrane recruitment, possibly explaining the limited effect of PKC inhibitors to durably suppress MAPK in UM. The findings nominate RasGRP3 as a therapeutic target for cancers driven by oncogenic GNAQ/11.
Pubmed ID: 28486107 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
A portal that provides visualization, analysis and download of large-scale cancer genomics data sets.
View all literature mentionsThis recombinant monoclonal targets YAP
View all literature mentionsThis monoclonal targets RASGRP3 (phospho T133) antibody [EPNCIR148]
View all literature mentionsThis polyclonal targets RASGRP 4 antibody
View all literature mentionsThis polyclonal targets RASGRP2 antibody
View all literature mentionsThis monoclonal targets Human Rsk1, phospho (Thr359 / Ser363)
View all literature mentionsThis unknown targets
View all literature mentionsThis monoclonal targets GLU-GLU
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis polyclonal targets Raf-B (C-19)
View all literature mentionsThis monoclonal targets RasGRP3
View all literature mentionsThis monoclonal targets c-Myc
View all literature mentionsThis monoclonal targets Met
View all literature mentionsThis polyclonal targets Cleaved PARP (Asp214) (Human Specific)
View all literature mentionsThis monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)
View all literature mentionsThis polyclonal targets Phospho-MEK1/2 (Ser217/221)
View all literature mentionsThis monoclonal targets PKCbetaII
View all literature mentionsThis polyclonal targets PRKCD
View all literature mentionsThis polyclonal targets PRKCB
View all literature mentionsThis polyclonal targets Prkcb
View all literature mentionsThis polyclonal targets PRKCH MaxPab mouse polyclonal antibody (B02)
View all literature mentionsThis monoclonal targets PKC gamma
View all literature mentionsThis monoclonal targets PKC epsilon
View all literature mentionsThis monoclonal targets PKCθ
View all literature mentionsThis monoclonal targets PKC-iota
View all literature mentionsThis monoclonal targets PKCzeta
View all literature mentionsThis unknown targets PKC delta
View all literature mentionsMus musculus with name J:NU from IMSR.
View all literature mentionsCell line Ramos is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions